1. Market Research
  2. > Chronic Disease Industry

rheumatoid arthritis Industry, August 2017 Market Reports from Top Publishers

You might be interested in: Therapy, Infectious Disease, Arthritis, Orthopedic Prosthesis, Diagnostics, Autoimmune Disease, Biosimilar, Injectable Delivery, Analgesic, Pharmaceutical, Musculoskeletal Disorder, Prosthesis, Anti Rheumatic, Eye Disease, Hospital, Sports, Hepatitis, Immunology, Magnetic Resonance Imaging, Monoclonal Antibody.


 
1-10 of 58 reports for rheumatoid arthritis

Purchase Reports From Reputable Market Research Publishers

Juvenile Rheumatoid Arthritis - Pipeline Insight, 2017

  • $ 1250
  • Industry report
  • July 2017
  • by Delve Insight

DelveInsight’s, “Juvenile Rheumatoid Arthritis-Pipeline Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Juvenile Rheumatoid Arthritis. ...

Rheumatoid Arthritis - Pipeline Review, H1 2017

  • $ 2500
  • Company report
  • June 2017
  • by Global Markets Direct

Rheumatoid Arthritis - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis - Pipeline Review, H1 2017, provides an ...

The 2018-2023 World Outlook for Rheumatoid Arthritis (RA) Monoclonal Antibodies (mAb)

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for rheumatoid arthritis (RA) monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential ...

Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

  • $ 4995
  • Industry report
  • April 2017
  • by GBI Research

Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs Summary ...

Global Rheumatoid Arthritis Partnering 2010 to 2017

  • $ 1495
  • Industry report
  • April 2017
  • by Currentpartnering

Provides understanding and access to the rheumatoid partnering deals and agreements entered into by the worlds leading healthcare companies. Description The Global Rheumatoid Arthritis Partnering Terms ...

Rheumatoid Arthritis [2017]

  • $ 8355
  • Industry report
  • April 2017
  • by Firstword Pharma

How are biosimilar anti-TNFs faring? Will your brand be affected? After several years on the US market, the availability of Pfizer’s Xeljanz in the EU is generally welcomed by KOLs; however, it now ...

Global Rheumatoid Arthritis Drug Market Outlook 2022

  • $ 1500
  • Industry report
  • March 2017
  • by Kuick Research

“Global Rheumatoid Arthritis Drug Market Outlook 2022” report gives comprehensive clinical and non-clinical insight on various trends associated with the rheumatoid arthritis drug market across the ...

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • February 2017
  • by GlobalData

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

Global Rheumatoid Arthritis Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017
  • by Fore Pharma

Fore Pharma announced the results of its Rheumatoid Arthritis patients study in a new report ‘Global Rheumatoid Arthritis Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

Rheumatoid Arthritis Pipeline Highlights – 2017

  • $ 720
  • Industry report
  • January 2017
  • by Fore Pharma

The latest report from Fore Pharma, Rheumatoid Arthritis Pipeline Highlights – 2017, provides most up-to-date information on key pipeline products in the global Rheumatoid Arthritis market. It covers ...

About 5100 reports for rheumatoid arthritis

Download Unlimited Documents from Trusted Public Sources

Healthcare Industry - Company Report, 2015

  • January 2015
    218 pages
  • Stroke  

    Arthritis  

    Healthcare  

  • Netherlands  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.